Candida infection and colonization among non-trauma emergency surgery patients

Virulence

Volumn 1, Issue 5, 2010, Pages 359-366

  Kourkoumpetis, Themistoklis ^a   Manolakaki, Dimitra ^b   Velmahos, George C ^b   Chang, Yuchiao ^c   Alam, Hasan B ^b   De Moya, Marc M ^b   Sailhamer, Elizabeth A ^a   Mylonakis, Eleftherios ^a  

^a Division of Infectious Diseases Laboratory   (United States)

^b Division of Trauma Emergency Surgery and Surgical Critical Care   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Candida; Candidiasis; Colonization; Costs; Emergency surgery; Risk factors

Indexed keywords

ADULT; AGED; BACTEREMIA; CANDIDA ALBICANS; CANDIDEMIA; CANDIDIASIS; CONTROLLED STUDY; EMERGENCY PATIENT; EMERGENCY SURGERY; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HIGH RISK POPULATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SURGICAL PATIENT; VENTILATOR ASSOCIATED PNEUMONIA;

BACTERIA (MICROORGANISMS); CANDIDA;

EID: 78249273926     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.1.5.12795     Document Type: Review

References (38)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-317.
2. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends 1991-2000. Clin Infect Dis 2004; 38:311-320.
3. Piazza O, Boccia MC, Iasiello A, Storti MP, Tufano R, Triassi M. Candidemia in Intensive Care patients. Risk factors and mortality. Minerva Anestesiol 2004; 70:63-69.
4. Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and metaanalysis. Intensive Care Med 2005; 31:1479-87.
5. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149:2349-2353.
6. Menzin J, Meyers JL, Friedman M, Perfect JR, Langston AA, Danna RP, et al. Mortality, length of hospitalization and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm 2009; 66:1711-1717.
7. Shorr AF, Gupta V, Sun X, Johannes RS, Spalding J, Tabak YP. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large US database. Crit Care Med 2009; 37:2519-2526.
8. Velmahos GC, Jurkovich GJ. The concept of acute care surgery: a vision for the not-so-distant future. Surgery 2007; 141:288-290.
9. Neary WD, Foy C, Heather BP, Earnshaw JJ. Identifying high-risk patients undergoing urgent and emergency surgery. Ann R Coll Surg Engl 2006; 88:151-156.
10. Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003; 3:685-702.
11. Toya SP, Schraufnagel DE, Tzelepis GE. Candiduria in intensive care units: association with heavy colonization and candidaemia. J Hosp Infect 2007; 66:201-206.
12. Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 1996; 22:73-88.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
14. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
15. Ewig S, Schlochtermeier M, Goke N, Niederman MS. Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest 2002; 121:1486-1492.
16. Agvald-Ohman C, Klingspor L, Hjelmqvist H, Edlund C. Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scand J Infect Dis 2008; 40:145-153.
17. Pacini D, Cerana M, Beltrame A, Di Biagio A, De Maria A. Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines. J Chemother 2007; 19:335-338.
18. Lipsett PA. Surgical critical care: fungal infections in surgical patients. Crit Care Med 2006; 34:215-224.
19. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis urvey. Clin Infect Dis 2001; 33:177-186.
20. Rangel-Frausto MS, Wiblin T, Blumberg HM, Saiman L, Patterson J, Rinaldi M, et al. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29:253-258.
21. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 2009; 48:265-273.
22. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20:1526-1530.
23. Krause W, Matheis H, Wulf K. Fungaemia and funguria after oral administration of Candida albicans. Lancet 1969; 1:598-599.
24. Chow JK, Golan Y, Ruthazer R, Karchmer AW, Carmeli Y, Lichtenberg DA, et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 2008; 36:1993-1998.
25. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile and Candida. Ann Intern Med 2002; 136:834-844.
26. Peleg AY, Tampakakis E, Fuchs BB, Eliopoulos GM, Moellering RC Jr, Mylonakis E. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc Natl Acad Sci USA 2008; 105:14585-14590.
27. Peleg AY, Hogan DA, Mylonakis E. Medically important bacterial-fungal interactions. Nat Rev Microbiol 2010; 8:340-349.
28. Rentz AM, Halpern MT, Bowden R. The impact of candidemia on length of hospital stay, outcome overall cost of illness. Clin Infect Dis 1998; 27:781-788.
29. Miller LG, Hajjeh RA, Edwards JE Jr. Estimating the cost of nosocomial candidemia in the united states. Clin Infect Dis 2001; 32:1110.
30. Zaoutis TE, Greves HM, Lautenbach E, Bilker WB, Coffin SE. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J 2004; 23:635-641.
31. Chakrabarti C, Sood SK, Parnell V, Rubin LG. Prolonged candidemia in infants following surgery for congenital heart disease. Infect Control Hosp Epidemiol 2003; 24:753-757.
32. Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 2005; 31:393-400.
33. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD. Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003; 124:2244-2255.
34. Mylonakis E, Flanigan TP. Antifungal prophylaxis with weekly fluconazole for patients with AIDS. Clin Infect Dis 1998; 27:1376-1378.
35. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell 2009; 8:1750-1758.
36. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007; 45:1735-1745.
37. Peman J, Canton E, Gobernado M. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2005; 24:23-30.
38. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002; 50:243-260.